(Q59313987)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20465316%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Understanding the relationship between the EQ-5D, SF-6D, HAQ and disease activity in inflammatory arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20465316%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20465316%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Douglas J Veale

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20465316%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Roisin Adams

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20465316%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Barry Bresnihan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20465316%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Oliver FitzGerald

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20465316%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Michael Barry

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20465316%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20465316%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20465316%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20465316%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20465316%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

477-487

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20465316%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/11533010-000000000-00000

2 February 2020

exact match

0 references

cites work

Cost effectiveness of adalimumab in the treatment of patients with moderate to severe rheumatoid arthritis in Sweden

1 reference

12 December 2020

Measuring health-related utility: why the disparity between EQ-5D and SF-6D?

1 reference

12 December 2020

The estimation of a preference-based measure of health from the SF-36.

1 reference

12 December 2020

Development and validation of response criteria in rheumatoid arthritis: steps towards an international consensus on prognostic markers

1 reference

12 December 2020

The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales

1 reference

12 December 2020

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis

1 reference

12 December 2020

Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis.

1 reference

12 December 2020

Variation in the estimation of quality-adjusted life-years by different preference-based instruments

1 reference

12 December 2020

Shedding new light onto the ceiling and floor? A quantile regression approach to compare EQ-5D and SF-6D responses

1 reference

12 December 2020

Using the health assessment questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis

1 reference

12 December 2020

Modeling and cost-effectiveness analysis of etanercept in adults with rheumatoid arthritis in Japan: a preliminary analysis.

1 reference

12 December 2020

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

12 December 2020

1 reference

12 December 2020

The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis

1 reference

12 December 2020

Why do patients with inflammatory arthritis often score states "worse than death" on the EQ-5D? An Investigation of the EQ-5D classification system.

1 reference

12 December 2020

Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores?

1 reference

12 December 2020

Economic burden of psoriatic arthritis

1 reference

12 December 2020

Are indirect utility measures reliable and responsive in rheumatoid arthritis patients?

1 reference

12 December 2020

Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D).

1 reference

12 December 2020

The time trade-off method: results from a general population study.

1 reference

12 December 2020

Measurement of patient outcome in arthritis

1 reference

12 December 2020

Modeling the cost-effectiveness of treatment of rheumatoid arthritis with rituximab using registry data from Southern Sweden

1 reference

12 December 2020

The episodic random utility model unifies time trade-off and discrete choice approaches in health state valuation

1 reference

12 December 2020

Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial.

1 reference

12 December 2020

Estimating the cost and health status consequences of treatment with TNF antagonists in patients with psoriatic arthritis

1 reference

12 December 2020

Modelling the cost effectiveness of TNF- antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry

1 reference

12 December 2020

The economic cost and social and psychological impact of musculoskeletal conditions. National Arthritis Data Work Groups.

1 reference

12 December 2020

UK cost-utility analysis of rituximab in patients with rheumatoid arthritis that failed to respond adequately to a biologic disease-modifying antirheumatic drug

1 reference

12 December 2020

EQ-5D versus SF-6D in an older, chronically Ill patient group

1 reference

12 December 2020

A comparison of four indirect methods of assessing utility values in rheumatoid arthritis

1 reference

12 December 2020

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

1 reference

12 December 2020

Economic consequences of the progression of rheumatoid arthritis in Sweden

1 reference

12 December 2020

Validity of Euroqol--a generic health status instrument--in patients with rheumatoid arthritis. Economic and Health Outcomes Research Group.

1 reference

12 December 2020

Economic analysis of health technologies and programmes. A Spanish proposal for methodological standardisation

1 reference

12 December 2020

Modelling covariates for the SF-6D standard gamble health state preference data using a nonparametric Bayesian method

1 reference

12 December 2020

Exploring uncertainty in cost-effectiveness analysis.

1 reference

12 December 2020

Comparison of EQ-5D and SF-6D utilities in mental health patients.

1 reference

12 December 2020

Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK.

1 reference

12 December 2020